Sandeep M. Nayak - Concepedia

Author

Sandeep M. Nayak

Johns Hopkins University ORCID

Also Known As

Sandeep M. Nayak, Sandeep M Nayak, Sandeep M. Nayak, Sandeep Manel Nayak, Sandeep Nayak, Sandeep M. Nayak

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Multidisciplinary Association for Psychedelic Studies Behavioral Pharma (United States)Yale University

About

Sandeep M. Nayak is an author at Johns Hopkins University specializing in medicine, health sciences, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	266
2	Health Sciences	4	4	71
3	Engineering	1	1	30
4	Nursing	1	1	11
5	Public Health	1	1	11

Sandeep M. Nayak

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Single-Dose Psilocybin Treatment for Major Depressive Disorder Charles L. Raison, Gerard Sanacora, Joshua Woolley, JAMA	2023	423
Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy Natalie Gukasyan, Sandeep M. Nayak Transcultural Psychiatry PsychotherapyPsychopharmacologyPlacebo EffectsPsychedelic-assisted TreatmentSocial Sciences	2021	139
Belief changes associated with psychedelic use Sandeep M. Nayak, Manvir Singh, David B. Yaden, Journal of Psychopharmacology	2022	77
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey Sandeep M. Nayak, Hillary Jackson, Nathan D. Sepeda, Frontiers in Psychiatry	2023	73
A Single Belief-Changing Psychedelic Experience Is Associated With Increased Attribution of Consciousness to Living and Non-living Entities Sandeep M. Nayak, Roland R. Griffiths Frontiers in Psychology	2022	70
Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports Sandeep M. Nayak, Natalie Gukasyan, Frederick S. Barrett, Pharmacopsychiatry	2021	65
Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying Mary M. Sweeney, Sandeep M. Nayak, Ethan Hurwitz, PLoS ONE	2022	51
Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use Natalie Gukasyan, Roland R. Griffiths, David B. Yaden, Journal of Psychopharmacology	2023	48
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, PLoS ONE	2024	46
Reconsidering “dissociation” as a predictor of antidepressant efficacy for esketamine David S. Mathai, Sandeep M. Nayak, David B. Yaden, Psychopharmacology PsychiatryMedicinePsychotropic MedicationDepressionPsychopharmacology	2023	33

Page 1